NCT07697872

Brief Summary

This observational study evaluates whether a machine-learning algorithm, a computer program that learns patterns from data, can accurately diagnose cholestasis in newborns. Cholestasis refers to reduced or blocked bile flow from the liver, which can lead to liver damage. A severe form of cholestasis is biliary atresia, a condition where the bile ducts are damaged or absent, requiring early treatment to prevent long-term harm. The study involves infants from birth, both healthy and those potentially affected by cholestasis, recruited from four UK hospitals. It addresses two primary aims:

  • Accuracy of Diagnosis: Can the machine-learning algorithm accurately identify cholestasis and biliary atresia using parent-provided stool images? This will be assessed by measuring sensitivity (the ability to correctly detect true cases) and specificity (the ability to correctly identify infants without the condition).
  • Feasibility of Screening: Is using parent-provided images a feasible and acceptable screening method for early detection? To evaluate these aims, researchers will compare two groups:
  • Infants with abnormal stool images who are subsequently diagnosed with cholestasis or biliary atresia.
  • Infants with normal stool images who do not develop biliary atresia. This comparison will help determine the algorithm's ability to distinguish between infants with and without these conditions. Parents will:
  • Take smartphone photos of their baby's dirty diapers at 14, 21, and 28 days of age.
  • Upload the images for analysis by the algorithm.
  • Provide feedback on their experience with this screening process. The study seeks to determine if parent-submitted stool images can serve as a practical early screening tool for cholestasis, potentially enabling faster diagnosis and improved outcomes for affected infants.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,350

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Apr 2025Sep 2026

First Submitted

Initial submission to the registry

February 28, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
1.3 years until next milestone

First Posted

Study publicly available on registry

July 13, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

July 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1.5 years

First QC Date

February 28, 2025

Last Update Submit

July 6, 2026

Conditions

Keywords

Neonatal cholestasisBiliary atresia diagnosisNewborn stool analysisinfant liver diseasescreeningmachine learningAIimage analysis

Outcome Measures

Primary Outcomes (1)

  • Sensitivity & Specificity of an Algorithm in Detecting Cholestasis

    Sensitivity: The proportion of stool images from clinically confirmed cholestatic infants that are correctly classified as positive by the algorithm, calculated as a single estimate across all evaluable images collected between Day 14 and Day 34 of life, using an independent held-out test dataset. Specificity: The proportion of stool images from clinically confirmed non-cholestatic infants that are correctly classified as negative by the algorithm, calculated as a single estimate across all evaluable images collected between Day 14 and Day 34 of life, using an independent held-out test dataset.

    Stool images collected between Day 14 and Day 34 of life; evaluation performed once clinical confirmation of cholestasis status is complete (up to 6 months of age).

Secondary Outcomes (10)

  • Sensitivity & Specificity of an Algorithm in Detecting Biliary Atresia

    Stool images collected between Day 14 and Day 34 of life; evaluation performed once clinical confirmation of biliary atresia status is complete (up to 6 months of age).

  • Sensitivity & Specificity of an Algorithm in Detecting Abnormal Stool Appearance (Colour and/or Texture)

    Images collected in the third week (Day 14- Day 20), fourth week (Day 21- Day 27), and fifth week (Day 28- Day 34) of life; evaluation is performed once clinical confirmation is complete (up to 6 months of age).

  • Sensitivity & Specificity of an Algorithm in Detecting Biliary Atresia in Cholestatic Infants

    Data collected from children less than 6 months; evaluation is performed once clinical confirmation is complete (up to 6 months of age).

  • Impact of Repeat Stool Image on Diagnostic Reclassification Among Initially Positive Cases in the 3rd Week of Life

    Repeat stool images will be collected between Day 21 and Day 27 of life for infants with an initial positive result from Day 14-20; final outcome confirmation will occur through clinical follow-up (up to 6 months of age).

  • Parents / Guardians Comfort Level with Photo-Based Diagnostic Requests to Assist in the Diagnosis of Biliary Atresia

    Assessments will be completed by parents/guardians at the end of each child's participation in the study (up to 6 months of age).

  • +5 more secondary outcomes

Study Arms (3)

Retrospective Cholestasis Cohort

This group includes infants who were referred to a specialist paediatric liver unit for suspected cholestasis within the past 10 years. This cohort provides historical data to evaluate the machine-learning algorithm's performance using existing images and clinical outcomes. No new interventions or prospective data collection occur in this group.

Prospective Cholestasis Cohort

This group includes infants who are newly referred for cholestasis investigation to a specialist paediatric liver unit during the study period. Parents will provide stool images at 14, 21, and 28 days of life, 3 months, and 6 months using a smartphone. These images will be analysed by a machine-learning algorithm to assess whether early stool image screening can help detect cholestasis, including biliary atresia. Participants will also share feedback on their experience with this screening method. This cohort provides real-time prospective data to train and validate the algorithm.

Prospective Non-Cholestasis Cohort

This group consists of newborns born at specified hospitals who are the time of recruitment are not thought to be cholestatic. Parents will submit stool images at 14, 21, and 28 days of life, 3 months, and 6 months to provide a large dataset of normal stool images. This cohort serves as a control group, ensuring that the algorithm can distinguish between healthy and abnormal stool patterns.

Eligibility Criteria

AgeUp to 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Recruited from hospitals enrolled in the study.

You may qualify if:

  • All Arms:
  • Informed Consent: Parents/guardians can give informed consent for their child's participation in the study and can understand written English.
  • Retrospective Cholestasis Arm:
  • All infants, of any gestation, male and female who were referred to Birmingham Liver Unit from any hospital for investigation of suspected cholestasis within the previous 10 years before the study launch. At the time of the referral to Birmingham Liver Unit the children were under the age of 6 months and the children were referred before the start date of the study.
  • Prospective Cholestasis Arm:
  • All infants, of any gestation, male and female who were referred to Birmingham Liver Unit from any hospital for investigation of suspected cholestasis after the study launch. At the time of the referral to Birmingham Liver Unit the children were under the age of 6 months.
  • Prospective Non-Cholestasis Arm All infants, of any gestation, male and female \& aged less than 28 days, not thought to be cholestatic at the time of recruitment \& with the birth registered at any of the participating hospital trusts.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Birmingham Women's and Children's NHS Foundation Trust

Birmingham, United Kingdom

RECRUITING

MeSH Terms

Conditions

Biliary Atresia

Condition Hierarchy (Ancestors)

Bile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesDigestive System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2025

First Posted

July 13, 2026

Study Start

April 1, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

July 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations